The phosphorylation of the effector protein eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1) within the PAM pathway is associated with poor prognosis in breast cancer and other malignancies due to the presence of elevated p4EBP1 levels in tumors [77]. This evidence concerns the gene EIF4EBP1 and breast carcinoma.